SAFE-iPS - France's First Hospital-based Platform for the Production of Induced Pluripotent Stem Cells for the Regenerative Medicine of the Future
SAFE-iPS - France's First Hospital-based Platform for the Production of Induced Pluripotent Stem Cells for the Regenerative Medicine of the Future
Promoteur : University Hospital, Montpellier
Titre et résumé fournis en anglais par le registre source, reproduits sans traduction ni interprétation.
The objective of the study is to establish the first French hospital-based Good Manufacturing Practice (GMP)-compliant platform for the production of clinical-grade induced pluripotent stem cells (iPSCs) for future regenerative medicine applications. The primary objective is to generate, via the SAFE-iPS platform, 4 clinical-grade iPSC lines derived from peripheral blood samples taken from: * Two healthy male volunteers * Two healthy female volunteers These 4 iPSC lines will undergo comprehensive quality assessment including: * Expression of pluripotency markers * Genomic stability assessment * Absence of residual Sendai viral integration * Technical reproducibility assessment * Manufacturing efficiency assessment * Preliminary medico-economic evaluation This project aims to demonstrate that the SAFE-iPS manufacturing process can be successfully transferred to a hospital Good Manufacturing Practice (GMP) environment and can reproducibly generate clinical-grade iPSC lines meeting international quality standards for future regenerative medicine applications. It also aims to establish the first French public hospital platform dedicated to routine GMP production of clinical-grade iPSCs.
Vous quittez essai-clinique.com pour le site externe clinicaltrials.gov, géré par l’organisme responsable de l’annonce. La candidature, les questions d’éligibilité et toute information médicale se traitent uniquement là-bas.
Important
essai-clinique.com ne recueille pas de candidature et ne détermine pas votre éligibilité. Ne transmettez aucune information médicale au site.
Les critères affichés sont une synthèse des informations disponibles. Seul l’organisme responsable de l’étude peut confirmer l’éligibilité d’une personne.